<?xml version="1.0" encoding="UTF-8"?>
<p>TLR4 is a receptor to LPS and leads to NFkB activation and (among others) hepatic inflammation. When administered orally to rats fed with a high-fat diet, Ang1-7 lowered hepatic inflammation, notably through a modulation of a metabolic pathway involving TLR4 (
 <xref rid="B81" ref-type="bibr">81</xref>). Moreover, promoting the effects of the Ang1-7/MAS receptor axis using medication also improves the aforementioned cytokines and oxidative stress in obese mice, with a protective effect against diabetic cardiomyopathy (
 <xref rid="B82" ref-type="bibr">82</xref>).
</p>
